Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-scFv)  (IGFV-129)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet